ClinConnect ClinConnect Logo
Search / Trial NCT06113211

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

Launched by HENRY FORD HEALTH SYSTEM · Oct 27, 2023

Trial Information

Current as of November 11, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well nonopioid pain management works compared to traditional opioid pain relief after a specific surgery called open reduction and internal fixation (ORIF) for broken bones, particularly in the collarbone area. The goal is to find a safer way to manage pain after surgery, considering the risks associated with opioid use. Patients involved in the study will be randomly assigned to either receive a nonopioid pain control regimen or the standard opioid treatment. If a patient still experiences pain, they may be given a small prescription of oxycodone for additional relief.

To participate in this study, you need to be an adult over 18 years old and scheduled for this type of surgery at one of the participating hospitals. However, certain conditions may exclude you, such as allergies to specific pain medications, a history of substance abuse, or certain medical issues like kidney problems. Throughout the trial, patients will be monitored to ensure their pain is managed effectively, and they will have ongoing support from the medical team if they need help with pain control after going home.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult patients over age eighteen and scheduled for primary open reduction internal fixation following a traumatic fracture at Henry Ford Hospital (Detroit, Michigan, United States), and Henry Ford West Bloomfield Hospital (West Bloomfield, Michigan, United States) will be eligible for inclusion in this study. All patients will be met in our abulatory orthopedic clinics. All surgeries will be performed by a fellowship trained truama surgeons.
  • Exclusion Criteria:
  • patients with a medical history of known allergies or intolerance to allergies or intolerance to Motrin, Lyrica, Tylenol, tramadol, Zanaflex
  • substantial alcohol or drug abuse
  • pregnancy
  • history of narcotics within 6 months of surgery
  • renal impairment, peptic ulcer disease, GI bleeding.

About Henry Ford Health System

Henry Ford Health System is a comprehensive, nonprofit healthcare organization based in Detroit, Michigan, renowned for its commitment to advancing medical research and patient care. With a robust network of hospitals, outpatient facilities, and specialty clinics, Henry Ford Health System is dedicated to innovation in clinical trials, focusing on translating scientific discoveries into effective treatments. The organization emphasizes multidisciplinary collaboration, leveraging its extensive resources and expertise to address diverse health challenges. Through its clinical research initiatives, Henry Ford Health System aims to enhance patient outcomes and contribute to the advancement of medical knowledge on both a local and global scale.

Locations

Detroit, Michigan, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported